About
Profile
We create breakthrough products – in diagnostics, medical devices, nutrition and branded generic pharmaceuticals – that help you, your family and your community lead healthier lives, full of unlimited possibilities. Today, 103,000 of us are working to
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
ABT
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Abbott Q2 results top consensus as base business offsets COVID impact
- Abbott Laboratories Non-GAAP EPS of $1.08 beats by $0.03, revenue of $10B beats by $280M
- Abbott seen reporting lower Q2 revenue, due in part to less COVID testing
- Catalyst Watch: Microsoft-Activision Blizzard drama, Splunk event and Nasdaq 100 rebalancing countdown
- Earnings week ahead: Tesla, Netflix, Johnson & Johnson, Bank of America and more
- Goldman Sachs sees rays of hope in underperforming health sector
- BTIG unveils top picks for rest of '23: D.R. Horton, CrowdStrike, DraftKings among names
- FDA approves Abbott dual-chamber leadless pacemaker Aveir DR
- Medicare revises guidance on drug price negotiations amid lawsuits
- Abbott gains expanded coverage for glucose monitoring device in France
- Abbott names Philip Boudreau CFO effective Sept. 1
- Abbott Laboratories declares $0.51 dividend
- Abbott alleges former scientist in its nutrition unit stole trade secrets
- Morgan Stanley's top medtech picks are Medtronic, Alphatec, Becton Dickinson
- Abbott, IQVIA, Global Fund, partners commit $54M to boost laboratory system for pandemics
- Abbott boasts of heart failure reduction data for CardioMEMS device
- Abbott, other baby-formula makers see FTC probe over collusion - report
- Abbott recalled baby formula claims tossed by federal judge
- Abbott gains approval of TactiFlex ablation catheter treatment
- Stereotaxis stock rises after pact with Abbott to improve abnormal heartbeat treatment
